Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Renal Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes Mellitus and Nephropathy

NCT00308347 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00308347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00308347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Renal Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes Mellitus and Nephropathy
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
May 31, 1996
Completion date
April 30, 2001
Enrollment
1,513 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

nephropathy, type 2 diabetes